Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC)
- PMID: 20816036
- PMCID: PMC3000882
- DOI: 10.4088/JCP.09m05094blu
Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC)
Abstract
Objective: Although clinical studies have documented that specific anxiety disorders are associated with impaired psychosocial functioning, little is known regarding their comparative effects on health-related quality of life within a general population. The current analysis compares health-related quality of life in a US community-dwelling sample of adults with DSM-IV social anxiety disorder, generalized anxiety disorders (GAD), panic disorder, and specific phobia.
Method: A face-to-face survey of a US nationally representative sample of over 43,000 adults aged 18 years and older residing in households and group quarters was conducted. Prevalence of DSM-IV anxiety disorders and relative associations with health-related quality of life indicators were examined. The survey was conducted from 2001 to 2002.
Results: Roughly 9.8% of respondents met diagnostic criteria for at least 1 of 4 twelve-month DSM-IV anxiety disorders which, relative to the non-anxiety-disordered general population, were each associated with lower personal income, increased rates of 12-month physical conditions, and greater numbers of Axis I and Axis II DSM-IV psychiatric conditions. After adjusting for sociodemographic and clinical correlates, including other anxiety disorders, GAD was associated with significant decrements in the SF-12 mental component summary score. In similar models, GAD and, to a lesser extent, panic disorder were significantly associated with impairment in social functioning, role emotional, and mental health SF subscales.
Conclusions: GAD, followed by panic disorder, appears to exact significant and independent tolls on health-related quality of life. Results underscore the importance of prompt and accurate clinical identification and improving access to effective interventions for these disorders.
© Copyright 2011 Physicians Postgraduate Press, Inc.
Similar articles
-
Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Psychol Med. 2005 Dec;35(12):1747-59. doi: 10.1017/S0033291705006069. Epub 2005 Oct 5. Psychol Med. 2005. PMID: 16202187
-
Age at onset of generalized anxiety disorder in older adults.Am J Geriatr Psychiatry. 2009 Jun;17(6):455-64. doi: 10.1097/jgp.0b013e31818f3a93. Am J Geriatr Psychiatry. 2009. PMID: 19472431
-
Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample.J Psychiatr Res. 2012 May;46(5):659-66. doi: 10.1016/j.jpsychires.2012.02.011. Epub 2012 Mar 23. J Psychiatr Res. 2012. PMID: 22444600 Free PMC article.
-
Human and economic burden of generalized anxiety disorder.Depress Anxiety. 2008;25(1):72-90. doi: 10.1002/da.20257. Depress Anxiety. 2008. PMID: 17146763 Review.
-
Public health perspectives on generalized anxiety disorder.J Clin Psychiatry. 2004;65 Suppl 13:3-7. J Clin Psychiatry. 2004. PMID: 15384930 Review.
Cited by
-
Results of a randomized controlled superiority trial of the effect of modified collaborative assessment vs. standard assessment on patients' readiness for psychotherapy (CO-ASSM-RCT).Trials. 2024 Oct 25;25(1):716. doi: 10.1186/s13063-024-08517-8. Trials. 2024. PMID: 39456051 Free PMC article. Clinical Trial.
-
Case report: Advances in treating ligyrophobia with third-generation ACT approach.Front Psychiatry. 2024 Sep 26;15:1425872. doi: 10.3389/fpsyt.2024.1425872. eCollection 2024. Front Psychiatry. 2024. PMID: 39391078 Free PMC article.
-
Discriminative capacity of the Spanish version of the Inventory of Depression and Anxiety Symptoms-II (IDAS-II) for detecting DMS-5 specific disorders and poor quality of life in a clinical sample.Health Qual Life Outcomes. 2024 Jul 18;22(1):56. doi: 10.1186/s12955-024-02270-x. Health Qual Life Outcomes. 2024. PMID: 39020397 Free PMC article.
-
A Complex Relationship between Quality of Life, Anxiety, and Depression among General Population during Second Year of COVID-19 Pandemic: A Population-Based Study.J Clin Med. 2024 Jun 30;13(13):3874. doi: 10.3390/jcm13133874. J Clin Med. 2024. PMID: 38999440 Free PMC article.
-
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients.Int Clin Psychopharmacol. 2024 Nov 1;39(6):350-360. doi: 10.1097/YIC.0000000000000536. Epub 2024 Feb 2. Int Clin Psychopharmacol. 2024. PMID: 38299624 Free PMC article.
References
-
- Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JRT, Ballender JC, Fyer AJ. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427–435. - PubMed
-
- Kessler RC, Greenberg PE. The economic burden of anxiety and stress disorders. In: Davis K, editor. Neuropsychopharmacology: The fifth generation of progress. The American College of Neuropsychopharmacology and Lippincott Williams & Wilkins; Baltimore, MD: 2002.
-
- Rice DP, Miller LS. Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry. 1998;173:4–9. - PubMed
-
- Wittchen H-U. Generalized anxiety disorder: Prevalence, burden, and cost to society. Depress Anxiety. 2002;16:162–171. - PubMed
Publication types
MeSH terms
Grants and funding
- Z01 AA000449-04/ImNIH/Intramural NIH HHS/United States
- DA023200/DA/NIDA NIH HHS/United States
- R01 DA020783/DA/NIDA NIH HHS/United States
- R01 DA019606/DA/NIDA NIH HHS/United States
- T32 MH016434/MH/NIMH NIH HHS/United States
- Z01 AA000449/ImNIH/Intramural NIH HHS/United States
- Z99 AA999999/ImNIH/Intramural NIH HHS/United States
- K02 DA023200/DA/NIDA NIH HHS/United States
- MH-076051/MH/NIMH NIH HHS/United States
- R01 MH076051/MH/NIMH NIH HHS/United States
- U18 HS016097/HS/AHRQ HHS/United States
- DA019606/DA/NIDA NIH HHS/United States
- AA014223/AA/NIAAA NIH HHS/United States
- K05 AA014223/AA/NIAAA NIH HHS/United States
- DA020783/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
